Avarent acquired by NSF International

LIBERTYVILLE - Avarent LLC, a consulting firm with expertise in medical device products/processes development, design control, validation, quality assurance and regulatory compliance has been acquired by Ann Arbor, Michigan-based company NSF International.

Terms of the acquisition were not announced. NSF is a provider of regulatory compliance, quality systems, analytical testing, education and consulting services for the medical device sector.

Avarent will be renamed NSF Avarent.

NSF International said the acquisition adds to it's portfolio of medical device services, combining Avarent's expertise with NSF International's experience in regulatory compliance and quality management systems throughout the medical device product life cycle.

"The addition of Avarent's technical production process and validation services and technical compliance consulting allows us to go beyond traditional consulting services to reduce costs for our medical device customers through improved operational efficiency," said Messa. "Together, we will provide our clients with more comprehensive solutions that ensure the design and manufacture of safer, higher quality medical devices."

Avarent founder by Ian Fleming, as well Thomas Dzierozynski, will join NSF International as executive vice presidents, reporting to Elaine Messa, president of NSF Health Sciences Medical Device Consulting, and will lead the integration of Avarent services into NSF Medical Device Consulting.

"NSF International and Avarent share the same commitment to delivering smart solutions focused first on patient safety and regulatory compliance. By combining our expertise, Avarent and NSF clients will have access to leading edge consultants dedicated to optimizing medical device design and manufacturing while mitigating risk and ensuring quality and regulatory compliance throughout the product life cycle," said Fleming.

The acquisition was made through NSF International's Global Health Sciences Division, and builds on NSF's 2012 acquisition of Washington D.C.-based regulatory compliance consulting firm Becker & Associates and U.K.-based medical device training and consulting firm Pink Associates, as well as NSF's 2011 acquisition of Pharmalytica, a GLP and GMP contract laboratory.